Joint FDA panel recommends OK for Avedro's eye treatment

A joint meeting of 2 FDA advisory panels backs the use of Avedro's cross-linking technology to treat 2 eye conditions.

Avedro said a joint meeting of 2 FDA advisory panels

considering its corneal cross-linking technology to treat 2 eye conditions this week voted to recommend approval.

Avedro Inc., Food & Drug Administration (FDA)

News Well, Optical/Ophthalmic, Regulatory/Compliance

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1C4WPw2